lubiprostone has been researched along with Gastrointestinal Hemorrhage in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amagase, K; Hayashi, S; Kurata, N; Takeuchi, K; Yamaguchi, A | 1 |
1 other study(ies) available for lubiprostone and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors.
Topics: Alprostadil; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cystic Fibrosis Transmembrane Conductance Regulator; Gastrointestinal Hemorrhage; Gastrointestinal Motility; Intestinal Mucosa; Intestine, Small; Lubiprostone; Male; Naphthalenes; Nitric Oxide Synthase Type II; Phenylbutyrates; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP4 Subtype; Tumor Necrosis Factor-alpha | 2014 |